Correlation Between DiaMedica Therapeutics and Boundless Bio,

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and Boundless Bio, Common, you can compare the effects of market volatilities on DiaMedica Therapeutics and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Boundless Bio,.

Diversification Opportunities for DiaMedica Therapeutics and Boundless Bio,

-0.53

Correlation Coefficient

DiaMedica Therapeutics  Boundless Bio,

Excellent diversification

The 3 months correlation between DiaMedica and Boundless is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Boundless Bio, go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Boundless Bio,

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.16 times more return on investment than Boundless Bio,. However, DiaMedica Therapeutics is 1.16 times more volatile than Boundless Bio, Common. It trades about 0.22 of its potential returns per unit of risk. Boundless Bio, Common is currently generating about 0.1 per unit of risk. If you would invest  470.00  in DiaMedica Therapeutics on September 23, 2024 and sell it today you would earn a total of  171.00  from holding DiaMedica Therapeutics or generate 36.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  Boundless Bio, Common

DiaMedica Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Boundless Bio, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with DiaMedica Therapeutics and Boundless Bio,

The main advantage of trading using opposite DiaMedica Therapeutics and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.

The idea behind DiaMedica Therapeutics and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.